These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32613069)

  • 1. Key considerations for comprehensive validation of an RNA fusion NGS panel.
    Barua S; Wang G; Mansukhani M; Hsiao S; Fernandes H
    Pract Lab Med; 2020 Aug; 21():e00173. PubMed ID: 32613069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of an RNA Sequencing Assay for Gene Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tumors.
    Peng H; Huang R; Wang K; Wang C; Li B; Guo Y; Li M; Zhang D; Dong H; Chen H; Chen C; Xu Q; Li F; Tian L; Wu J
    J Mol Diagn; 2021 Feb; 23(2):223-233. PubMed ID: 33271368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors.
    Martínez-Fernández P; Pose P; Dolz-Gaitón R; García A; Trigo-Sánchez I; Rodríguez-Zarco E; Garcia-Ruiz M; Barba I; Izquierdo-García M; Valero-Garcia J; Ruiz C; Lázaro M; Carbonell P; Gargallo P; Méndez C; Ríos-Martín JJ; Palmeiro-Uriach A; Camarasa-Lillo N; Forteza-Vila J; Calabria I
    J Pers Med; 2021 Apr; 11(5):. PubMed ID: 33947144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.
    Ju S; Cui Z; Hong Y; Wang X; Mu W; Xie Z; Zeng X; Su L; Lin X; Zhang Z; Zhang Q; Song X; You S; Chen R; Chen W; Xu C; Zhao J
    Cancer; 2023 Aug; 129(15):2422-2430. PubMed ID: 37096747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay.
    Bergeron D; Chandok H; Nie Q; Prego M; Soucy M; Kelly K; Ananda G; Hesse A; Reddi HV
    J Mol Med (Berl); 2022 Feb; 100(2):323-335. PubMed ID: 35013752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples.
    Capone I; Bozzi F; Dagrada GP; Verderio P; Conca E; Busico A; Testi MA; Monti V; Duca M; Proto C; Damian S; Piccolo A; Perrone F; Tamborini E; Devecchi A; Collini P; Lorenzini D; Vingiani A; Agnelli L; Pruneri G
    Explor Target Antitumor Ther; 2022; 3(5):582-597. PubMed ID: 36338518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors.
    Kim M; Lee C; Hong J; Kim J; Jeong JY; Park NJ; Kim JE; Park JY
    Cancer Res Treat; 2023 Apr; 55(2):429-441. PubMed ID: 36470260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection.
    Bormann Chung C; Lee J; Barritault M; Bringuier PP; Xu Z; Huang WY; Beharry A; Castillo J; Christiansen J; Lin JC; Sheffield BS
    J Mol Diagn; 2022 Jan; 24(1):18-32. PubMed ID: 34656759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing-Based NTRK Fusion Detection in South Korea.
    Lee SE; Lee MS; Jeon YK; Shim HS; Kang J; Kim J; Choi YL
    Cancer Res Treat; 2023 Jan; 55(1):28-40. PubMed ID: 35167738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-Adherent Clinical Validation of a Comprehensive 170-Gene DNA/RNA Panel for Determination of Small Variants, Copy Number Variations, Splice Variants, and Fusions on a Next-Generation Sequencing Platform in the CLIA Setting.
    Boyle TA; Mondal AK; Saeed-Vafa D; Ananth S; Ahluwalia P; Kothapalli R; Chaubey A; Roberts E; Qin D; Magliocco AM; Rojiani AM; Kolhe R
    Front Genet; 2021; 12():503830. PubMed ID: 34093633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical validation and implementation of a pan cancer next-generation sequencing panel, CANSeq
    Schilter KF; Smith BA; Nie Q; Stoll K; Felix JC; Jarzembowski JA; Reddi HV
    Front Genet; 2023; 14():1067457. PubMed ID: 36845394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia.
    Vicente-Garcés C; Esperanza-Cebollada E; Montesdeoca S; Torrebadell M; Rives S; Dapena JL; Català A; Conde N; Camós M; Vega-García N
    Front Mol Biosci; 2022; 9():854098. PubMed ID: 35463953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid Tumors.
    Froyen G; Geerdens E; Berden S; Cruys B; Maes B
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
    Beg S; Bareja R; Ohara K; Eng KW; Wilkes DC; Pisapia DJ; Zoughbi WA; Kudman S; Zhang W; Rao R; Manohar J; Kane T; Sigouros M; Xiang JZ; Khani F; Robinson BD; Faltas BM; Sternberg CN; Sboner A; Beltran H; Elemento O; Mosquera JM
    Transl Oncol; 2021 Jan; 14(1):100944. PubMed ID: 33190043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing.
    Ramani NS; Patel KP; Routbort MJ; Alvarez H; Broaddus R; Chen H; Rashid A; Lazar A; Lucas FAS; Yao H; Manekia J; Dang H; Barkoh BA; Medeiros LJ; Luthra R; Roy-Chowdhuri S
    Arch Pathol Lab Med; 2021 Nov; 145(11):1405-1412. PubMed ID: 33493304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
    Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
    Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.